1. Home
  2. PEN vs NOVT Comparison

PEN vs NOVT Comparison

Compare PEN & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEN
  • NOVT
  • Stock Information
  • Founded
  • PEN 2004
  • NOVT 1968
  • Country
  • PEN United States
  • NOVT United States
  • Employees
  • PEN N/A
  • NOVT N/A
  • Industry
  • PEN Medical/Dental Instruments
  • NOVT Industrial Machinery/Components
  • Sector
  • PEN Health Care
  • NOVT Miscellaneous
  • Exchange
  • PEN Nasdaq
  • NOVT Nasdaq
  • Market Cap
  • PEN 7.0B
  • NOVT 6.0B
  • IPO Year
  • PEN 2015
  • NOVT N/A
  • Fundamental
  • Price
  • PEN $244.98
  • NOVT $169.79
  • Analyst Decision
  • PEN Buy
  • NOVT Hold
  • Analyst Count
  • PEN 14
  • NOVT 1
  • Target Price
  • PEN $232.23
  • NOVT $169.00
  • AVG Volume (30 Days)
  • PEN 420.1K
  • NOVT 218.2K
  • Earning Date
  • PEN 10-30-2024
  • NOVT 11-05-2024
  • Dividend Yield
  • PEN N/A
  • NOVT N/A
  • EPS Growth
  • PEN N/A
  • NOVT N/A
  • EPS
  • PEN 0.89
  • NOVT 1.66
  • Revenue
  • PEN $1,163,776,000.00
  • NOVT $922,754,000.00
  • Revenue This Year
  • PEN $13.65
  • NOVT $10.75
  • Revenue Next Year
  • PEN $14.38
  • NOVT $9.68
  • P/E Ratio
  • PEN $276.50
  • NOVT $102.27
  • Revenue Growth
  • PEN 16.96
  • NOVT 3.86
  • 52 Week Low
  • PEN $148.00
  • NOVT $142.35
  • 52 Week High
  • PEN $277.34
  • NOVT $187.12
  • Technical
  • Relative Strength Index (RSI)
  • PEN 69.88
  • NOVT 47.09
  • Support Level
  • PEN $234.62
  • NOVT $162.40
  • Resistance Level
  • PEN $242.95
  • NOVT $183.85
  • Average True Range (ATR)
  • PEN 6.39
  • NOVT 5.21
  • MACD
  • PEN -0.13
  • NOVT -0.84
  • Stochastic Oscillator
  • PEN 98.61
  • NOVT 52.19

About PEN Penumbra Inc.

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.

About NOVT Novanta Inc.

Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.

Share on Social Networks: